459 related articles for article (PubMed ID: 31159823)
21. Combined effect of Hashimoto's thyroiditis and BRAF(V600E) mutation status on aggressiveness in papillary thyroid cancer.
Kim SJ; Myong JP; Jee HG; Chai YJ; Choi JY; Min HS; Lee KE; Youn YK
Head Neck; 2016 Jan; 38(1):95-101. PubMed ID: 25213729
[TBL] [Abstract][Full Text] [Related]
22. Papillary Thyroid Carcinoma Emerging from Hashimoto Thyroiditis Demonstrates Increased PD-L1 Expression, Which Persists with Metastasis.
Lubin D; Baraban E; Lisby A; Jalali-Farahani S; Zhang P; Livolsi V
Endocr Pathol; 2018 Dec; 29(4):317-323. PubMed ID: 30121940
[TBL] [Abstract][Full Text] [Related]
23. A higher frequency of circulating IL-22(+)CD4(+) T cells in Chinese patients with newly diagnosed Hashimoto's thyroiditis.
Guo H; Peng D; Yang XG; Wang Y; Xu BC; Ni JS; Meng W; Jiang YF
PLoS One; 2014; 9(1):e84545. PubMed ID: 24404171
[TBL] [Abstract][Full Text] [Related]
24. Hashimoto's Thyroiditis Does Not Affect Ultrasonographical, Cytological, and Histopathological Features in Patients with Papillary Thyroid Carcinoma.
Baser H; Ozdemir D; Cuhaci N; Aydin C; Ersoy R; Kilicarslan A; Cakir B
Endocr Pathol; 2015 Dec; 26(4):356-64. PubMed ID: 26481630
[TBL] [Abstract][Full Text] [Related]
25. The study of the coexistence of Hashimoto's thyroiditis with papillary thyroid carcinoma.
Zhang Y; Dai J; Wu T; Yang N; Yin Z
J Cancer Res Clin Oncol; 2014 Jun; 140(6):1021-6. PubMed ID: 24619663
[TBL] [Abstract][Full Text] [Related]
26. Thyrocyte interleukin-18 expression is up-regulated by interferon-γ and may contribute to thyroid destruction in Hashimoto's thyroiditis.
Liu Z; Wang H; Xiao W; Wang C; Liu G; Hong T
Int J Exp Pathol; 2010 Oct; 91(5):420-5. PubMed ID: 20586818
[TBL] [Abstract][Full Text] [Related]
27. [Clinico-pathological features of papillary thyroid cancer coexistent with Hashimoto's thyroiditis].
Molnár S; Győry F; Nagy E; Méhes G; Molnár C
Orv Hetil; 2017 Feb; 158(5):178-182. PubMed ID: 28132543
[TBL] [Abstract][Full Text] [Related]
28. Association between Hashimoto's thyroiditis and papillary thyroid carcinoma: a retrospective analysis of 305 patients.
Graceffa G; Patrone R; Vieni S; Campanella S; Calamia S; Laise I; Conzo G; Latteri M; Cipolla C
BMC Endocr Disord; 2019 May; 19(Suppl 1):26. PubMed ID: 31142293
[TBL] [Abstract][Full Text] [Related]
29. Comprehensive analysis of lncRNA-mediated ceRNA regulatory networks and key genes associated with papillary thyroid cancer coexistent with Hashimoto's thyroiditis.
Zhang Y; Tian Y
BMC Endocr Disord; 2022 Oct; 22(1):252. PubMed ID: 36266640
[TBL] [Abstract][Full Text] [Related]
30. Hashimoto's thyroiditis and papillary thyroid carcinoma. Are cytokeratin 19 and P63 proteins of any diagnostic value?
Divani SN; Kalodimos GP; Lioupis MA; Syrmos NC
Hell J Nucl Med; 2016; 19(3):250-253. PubMed ID: 27824965
[TBL] [Abstract][Full Text] [Related]
31. Changes in Treg numbers and activity in papillary thyroid carcinoma with and without Hashimoto's thyroiditis.
Zhao N; Liu X; Wu C; Liu Y; Zhao X; He X
J Int Med Res; 2020 Apr; 48(4):300060520919222. PubMed ID: 32314639
[TBL] [Abstract][Full Text] [Related]
32. Papillary thyroid carcinoma in children with Hashimoto's thyroiditis - a review of the literature between 2000 and 2020.
Sur ML; Gaga R; Lazăr C; Lazea C; Aldea C; Sur D
J Pediatr Endocrinol Metab; 2020 Dec; 33(12):1511-1517. PubMed ID: 33180046
[TBL] [Abstract][Full Text] [Related]
33. Clinical analysis of Hashimoto thyroiditis coexistent with papillary thyroid cancer in 1392 patients.
Liang J; Zeng W; Fang F; Yu T; Zhao Y; Fan X; Guo N; Gao X
Acta Otorhinolaryngol Ital; 2017 Oct; 37(5):393-400. PubMed ID: 29165434
[TBL] [Abstract][Full Text] [Related]
34. Thyroid cancer associated with Hashimoto thyroiditis: similarities and differences in an endemic area.
Hussein O; Abdelwahab K; Hamdy O; Awny S; Megahed NA; Hafez MT; Elalfi AF; Abdelaziz M; Gaballah K; Abdelkhalek M
J Egypt Natl Canc Inst; 2020 Jan; 32(1):7. PubMed ID: 32372240
[TBL] [Abstract][Full Text] [Related]
35. The Underestimated Impact of Hashimoto Thyroiditis on Thyroid Papillary Carcinoma.
Harmantepe AT; Ozdemir K; Bayhan Z; Kocer B
Updates Surg; 2024 Jun; 76(3):1085-1089. PubMed ID: 38687448
[TBL] [Abstract][Full Text] [Related]
36. The increased but non-predominant expression of Th17- and Th1-specific cytokines in Hashimoto's thyroiditis but not in Graves' disease.
Qin Q; Liu P; Liu L; Wang R; Yan N; Yang J; Wang X; Pandey M; Zhang JA
Braz J Med Biol Res; 2012 Dec; 45(12):1202-8. PubMed ID: 23090124
[TBL] [Abstract][Full Text] [Related]
37. Total thyroidectomy for the treatment of Hashimoto's thyroiditis coexisting with papillary thyroid carcinoma.
Kurukahvecioglu O; Taneri F; Yüksel O; Aydin A; Tezel E; Onuk E
Adv Ther; 2007; 24(3):510-6. PubMed ID: 17660159
[TBL] [Abstract][Full Text] [Related]
38. Heterogeneity of tissue IL-17 and tight junction proteins expression demonstrated in patients with autoimmune thyroid diseases.
Zake T; Skuja S; Kalere I; Konrade I; Groma V
Medicine (Baltimore); 2018 Jun; 97(25):e11211. PubMed ID: 29924048
[TBL] [Abstract][Full Text] [Related]
39. Hashimoto's thyroiditis predicts outcome in intrathyroidal papillary thyroid cancer.
Marotta V; Sciammarella C; Chiofalo MG; Gambardella C; Bellevicine C; Grasso M; Conzo G; Docimo G; Botti G; Losito S; Troncone G; De Palma M; Giacomelli L; Pezzullo L; Colao A; Faggiano A
Endocr Relat Cancer; 2017 Sep; 24(9):485-493. PubMed ID: 28696209
[TBL] [Abstract][Full Text] [Related]
40. Risk of lymph node metastases in multifocal papillary thyroid cancer associated with Hashimoto's thyroiditis.
Konturek A; Barczyński M; Nowak W; Wierzchowski W
Langenbecks Arch Surg; 2014 Feb; 399(2):229-36. PubMed ID: 24407910
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
